Neurocrine Company Profile

What is the competitive landscape for NEUROCRINE, and what generic alternatives to NEUROCRINE drugs are available?

NEUROCRINE has two approved drugs.

There are twenty-eight US patents protecting NEUROCRINE drugs.

There are two hundred and forty-three patent family members on NEUROCRINE drugs in forty countries and eighteen supplementary protection certificates in fifteen countries.

Summary for Neurocrine

International Patents:	243
US Patents:	28
Tradenames:	2
Ingredients:	2
NDAs:	2
Patent Litigation for Neurocrine:	See patent lawsuits for Neurocrine

Drugs and US Patents for Neurocrine

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Neurocrine	INGREZZA	valbenazine tosylate	CAPSULE;ORAL	209241-001	Apr 11, 2017		RX	Yes	No	10,851,104			Y
Neurocrine	INGREZZA	valbenazine tosylate	CAPSULE;ORAL	209241-003	Apr 23, 2021		RX	Yes	No	10,993,941
Neurocrine	INGREZZA	valbenazine tosylate	CAPSULE;ORAL	209241-003	Apr 23, 2021		RX	Yes	No
Neurocrine	INGREZZA	valbenazine tosylate	CAPSULE;ORAL	209241-003	Apr 23, 2021		RX	Yes	No	8,357,697
Neurocrine	ONGENTYS	opicapone	CAPSULE;ORAL	212489-002	Apr 24, 2020		RX	Yes	Yes	10,071,085		Y
Neurocrine	INGREZZA	valbenazine tosylate	CAPSULE;ORAL	209241-001	Apr 11, 2017		RX	Yes	No	11,026,939		Y
Neurocrine	ONGENTYS	opicapone	CAPSULE;ORAL	212489-002	Apr 24, 2020		RX	Yes	Yes	8,907,099			Y

International Patents for Neurocrine Drugs

Country	Patent Number	Estimated Expiration
Colombia	2018004589
World Intellectual Property Organization (WIPO)	2017112857
South Korea	20090079257
Australia	2010231961
European Patent Office	2481410
China	101553487
Israel	200020

Supplementary Protection Certificates for Neurocrine Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1907382	16C1016	France		PRODUCT NAME: OPICAPONE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE; REGISTRATION NO/DATE: EU/1/15/1066 20160628
1907382	57/2016	Austria		PRODUCT NAME: OPICAPON ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1066 (MITTEILUNG) 20160628
1907382	132016000123029	Italy		PRODUCT NAME: OPICAPONE O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE(ONGENTYS); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/15/1066, 20160628
1907382	PA2016036,C1907382	Lithuania		PRODUCT NAME: OPIKAPONAS ARBA JO FARMACINIU POZIURIU PRIIMTINOS DRUSKOS; REGISTRATION NO/DATE: EU/1/15/1066 20160624
1907382	C01907382/01	Switzerland		PRODUCT NAME: OPICAPON; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66547 26.04.2018
1907382	271 50011-2016	Slovakia		PRODUCT NAME: OPIKAPON VO VSETKYCH FORMACH CHRANENYCH ZA- KLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/15/1066/001 - EU/1/15/1066/010 20160628
1907382	CA 2016 00061	Denmark		PRODUCT NAME: OPICAPONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/15/1066 20160628

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Neurelis Inc
• Neurocrine